Article
Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study.
BMC family practice - 17 Feb 2018
Kirkegaard Pia, Edwards Adrian, Nielsen Trine Laura Overgaard, Ørntoft Torben Falck, Sørensen Karina Dalsgaard, Borre Michael, Bro Flemming
Abstract excerpt
BACKGROUND: Most health authorities do not recommend screening for prostate cancer with PSA tests in asymptomatic patients who are not at increased risk. However, opportunistic screening for prostate cancer is still wanted by many patients and it is widely used in primary care clinics, with potential for overdiagnosis and overtreatment. Better tools for risk assessment have been called for, to better target such...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
